Medical - Healthcare Information Services
Build Your Comparison
Side-by-side financial analysisStock Comparison
FORA vs CSGP vs Z vs INFU vs OPEN
Revenue, margins, valuation, and 5-year total return — side by side.
Real Estate - Services
Internet Content & Information
Medical - Instruments & Supplies
Real Estate - Services
FORA vs CSGP vs Z vs INFU vs OPEN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Medical - Healthcare Information Services | Real Estate - Services | Internet Content & Information | Medical - Instruments & Supplies | Real Estate - Services |
| Market Cap | $68M | $12.77B | $7.72B | $190M | $3.43B |
| Revenue (TTM) | $30M | $3.41B | $2.69B | $142M | $3.94B |
| Net Income (TTM) | $-5M | $25M | $61M | $8M | $-1.39B |
| Gross Margin | 46.8% | 77.4% | 73.3% | 56.7% | 7.9% |
| Operating Margin | -13.4% | -0.8% | 0.4% | 9.1% | -9.9% |
| Forward P/E | — | 22.1x | 14.1x | 22.2x | — |
| Total Debt | $12K | $1.14B | $536M | $3M | $193M |
| Cash & Equiv. | $13M | $1.73B | $773M | $3M | $962M |
FORA vs CSGP vs Z vs INFU vs OPEN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 21 | May 26 | Return |
|---|---|---|---|
| Forian Inc. (FORA) | 100 | 21.5 | -78.5% |
| CoStar Group, Inc. (CSGP) | 100 | 42.1 | -57.9% |
| Zillow Group, Inc. … (Z) | 100 | 34.2 | -65.8% |
| InfuSystem Holdings… (INFU) | 100 | 49.8 | -50.2% |
| Opendoor Technologi… (OPEN) | 100 | 25.4 | -74.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: FORA vs CSGP vs Z vs INFU vs OPEN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
FORA has the current edge in this matchup, primarily because of its strength in income & stability and growth exposure.
- beta 0.21
- Rev growth 50.1%, EPS growth 23.0%, 3Y rev CAGR 22.6%
- Lower volatility, beta 0.21, Low D/E 0.0%, current ratio 2.97x
- Beta 0.21, current ratio 2.97x
Among these 5 stocks, CSGP doesn't own a clear edge in any measured category.
Z ranks third and is worth considering specifically for value.
- Lower P/E (14.1x vs 22.2x)
INFU is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 240.1% 10Y total return vs CSGP's 43.4%
- 5.6% margin vs OPEN's -35.2%
- 7.9% ROA vs OPEN's -53.6%, ROIC 12.5% vs -15.8%
OPEN is the clearest fit if your priority is momentum.
- +6.7% vs CSGP's -62.1%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 50.1% revenue growth vs OPEN's -15.2% | |
| Value | Lower P/E (14.1x vs 22.2x) | |
| Quality / Margins | 5.6% margin vs OPEN's -35.2% | |
| Stability / Safety | Beta 0.21 vs OPEN's 3.14, lower leverage | |
| Dividends | Tie | None of these 5 stocks pay a meaningful dividend |
| Momentum (1Y) | +6.7% vs CSGP's -62.1% | |
| Efficiency (ROA) | 7.9% ROA vs OPEN's -53.6%, ROIC 12.5% vs -15.8% |
FORA vs CSGP vs Z vs INFU vs OPEN — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
FORA vs CSGP vs Z vs INFU vs OPEN — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
INFU leads in 2 of 6 categories
OPEN leads 1 • FORA leads 0 • CSGP leads 0 • Z leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
INFU leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
OPEN is the larger business by revenue, generating $3.9B annually — 131.0x FORA's $30M. INFU is the more profitable business, keeping 5.6% of every revenue dollar as net income compared to OPEN's -35.2%. On growth, CSGP holds the edge at +22.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $30M | $3.4B | $2.7B | $142M | $3.9B |
| EBITDAEarnings before interest/tax | -$4M | $278M | $221M | $26M | -$363M |
| Net IncomeAfter-tax profit | -$5M | $25M | $61M | $8M | -$1.4B |
| Free Cash FlowCash after capex | $2M | $241M | $431M | $20M | $1.1B |
| Gross MarginGross profit ÷ Revenue | +46.8% | +77.4% | +73.3% | +56.7% | +7.9% |
| Operating MarginEBIT ÷ Revenue | -13.4% | -0.8% | +0.4% | +9.1% | -9.9% |
| Net MarginNet income ÷ Revenue | -17.0% | +0.7% | +2.3% | +5.6% | -35.2% |
| FCF MarginFCF ÷ Revenue | +7.8% | +7.1% | +16.0% | +14.3% | +27.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | -2.9% | +22.5% | +18.4% | -3.0% | -37.6% |
| EPS Growth (YoY)Latest quarter vs prior year | -2.0% | +127.7% | +5.1% | +5.9% | -50.0% |
Valuation Metrics
OPEN leads this category, winning 2 of 6 comparable metrics.
Valuation Metrics
At 30.4x trailing earnings, INFU trades at a 98% valuation discount to CSGP's 1814.5x P/E. On an enterprise value basis, INFU's 7.5x EV/EBITDA is more attractive than CSGP's 71.6x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $68M | $12.8B | $7.7B | $190M | $3.4B |
| Enterprise ValueMkt cap + debt − cash | $55M | $12.2B | $7.5B | $190M | $2.7B |
| Trailing P/EPrice ÷ TTM EPS | -23.48x | 1814.46x | 354.81x | 30.39x | -2.63x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 22.11x | 14.10x | 22.16x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 71.63x | 28.65x | 7.55x | — |
| Price / SalesMarket cap ÷ Revenue | 2.24x | 3.93x | 2.99x | 1.33x | 0.78x |
| Price / BookPrice ÷ Book value/share | 2.27x | 1.52x | 1.67x | 3.47x | 3.41x |
| Price / FCFMarket cap ÷ FCF | 23.49x | 311.35x | 32.83x | 7.97x | 3.30x |
Profitability & Efficiency
INFU leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
INFU delivers a 14.0% return on equity — every $100 of shareholder capital generates $14 in annual profit, vs $-163 for OPEN. FORA carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to OPEN's 0.19x. On the Piotroski fundamental quality scale (0–9), INFU scores 8/9 vs OPEN's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -17.2% | +0.3% | +1.3% | +14.0% | -163.2% |
| ROA (TTM)Return on assets | -11.8% | +0.2% | +1.1% | +7.9% | -53.6% |
| ROICReturn on invested capital | -7.5% | -0.9% | -0.5% | +12.5% | -15.8% |
| ROCEReturn on capital employed | -8.2% | -0.8% | -0.6% | +14.3% | -11.7% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 5 | 7 | 8 | 5 |
| Debt / EquityFinancial leverage | 0.00x | 0.14x | 0.11x | 0.06x | 0.19x |
| Net DebtTotal debt minus cash | -$13M | -$589M | -$237M | $241,000 | -$769M |
| Cash & Equiv.Liquid assets | $13M | $1.7B | $773M | $3M | $962M |
| Total DebtShort + long-term debt | $12,137 | $1.1B | $536M | $3M | $193M |
| Interest CoverageEBIT ÷ Interest expense | -48.78x | 1.58x | 5.22x | 15.54x | -8.92x |
Total Returns (Dividends Reinvested)
Evenly matched — INFU and OPEN each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in INFU five years ago would be worth $4,979 today (with dividends reinvested), compared to $1,735 for FORA. Over the past 12 months, OPEN leads with a +671.4% total return vs CSGP's -62.1%. The 3-year compound annual growth rate (CAGR) favors OPEN at 13.3% vs CSGP's -29.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +2.4% | -54.1% | -51.3% | +12.3% | -26.4% |
| 1-Year ReturnPast 12 months | +2.4% | -62.1% | -52.5% | +52.2% | +671.4% |
| 3-Year ReturnCumulative with dividends | -7.3% | -64.7% | -32.9% | -7.6% | +45.6% |
| 5-Year ReturnCumulative with dividends | -82.7% | -65.7% | -72.3% | -50.2% | -73.2% |
| 10-Year ReturnCumulative with dividends | -90.5% | +43.4% | -7.6% | +240.1% | -58.6% |
| CAGR (3Y)Annualised 3-year return | -2.5% | -29.3% | -12.5% | -2.6% | +13.3% |
Risk & Volatility
Evenly matched — FORA and INFU each lead in 1 of 2 comparable metrics.
Risk & Volatility
FORA is the less volatile stock with a 0.21 beta — it tends to amplify market swings less than OPEN's 3.14 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. INFU currently trades 85.3% from its 52-week high vs CSGP's 30.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.21x | 0.45x | 1.15x | 1.22x | 3.14x |
| 52-Week HighHighest price in past year | $2.71 | $97.43 | $93.88 | $11.04 | $10.87 |
| 52-Week LowLowest price in past year | $1.64 | $29.53 | $31.48 | $5.38 | $0.51 |
| % of 52W HighCurrent price vs 52-week peak | +80.1% | +30.9% | +34.2% | +85.3% | +41.1% |
| RSI (14)Momentum oscillator 0–100 | 63.8 | 31.0 | 31.1 | 41.5 | 44.1 |
| Avg Volume (50D)Average daily shares traded | 40K | 7.0M | 4.0M | 172K | 36.8M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: CSGP as "Buy", Z as "Hold", INFU as "Buy", OPEN as "Hold". Consensus price targets imply 111.0% upside for Z (target: $68) vs 38.0% for OPEN (target: $6).
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Hold | Buy | Hold |
| Price TargetConsensus 12-month target | — | $61.18 | $67.75 | $15.00 | $6.17 |
| # AnalystsCovering analysts | — | 25 | 46 | 3 | 26 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — | — |
| Dividend StreakConsecutive years of raises | — | — | — | — | — |
| Dividend / ShareAnnual DPS | — | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.6% | +4.5% | +8.7% | +5.8% | 0.0% |
INFU leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). OPEN leads in 1 (Valuation Metrics). 2 tied.
FORA vs CSGP vs Z vs INFU vs OPEN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is FORA or CSGP or Z or INFU or OPEN a better buy right now?
For growth investors, Forian Inc.
(FORA) is the stronger pick with 50. 1% revenue growth year-over-year, versus -15. 2% for Opendoor Technologies Inc. (OPEN). InfuSystem Holdings, Inc. (INFU) offers the better valuation at 30. 4x trailing P/E (22. 2x forward), making it the more compelling value choice. Analysts rate CoStar Group, Inc. (CSGP) a "Buy" — based on 25 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — FORA or CSGP or Z or INFU or OPEN?
On trailing P/E, InfuSystem Holdings, Inc.
(INFU) is the cheapest at 30. 4x versus CoStar Group, Inc. at 1814. 5x. On forward P/E, Zillow Group, Inc. Class C is actually cheaper at 14. 1x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — FORA or CSGP or Z or INFU or OPEN?
Over the past 5 years, InfuSystem Holdings, Inc.
(INFU) delivered a total return of -50. 2%, compared to -82. 7% for Forian Inc. (FORA). Over 10 years, the gap is even starker: INFU returned +240. 1% versus FORA's -90. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — FORA or CSGP or Z or INFU or OPEN?
By beta (market sensitivity over 5 years), Forian Inc.
(FORA) is the lower-risk stock at 0. 21β versus Opendoor Technologies Inc. 's 3. 14β — meaning OPEN is approximately 1397% more volatile than FORA relative to the S&P 500. On balance sheet safety, Forian Inc. (FORA) carries a lower debt/equity ratio of 0% versus 19% for Opendoor Technologies Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — FORA or CSGP or Z or INFU or OPEN?
By revenue growth (latest reported year), Forian Inc.
(FORA) is pulling ahead at 50. 1% versus -15. 2% for Opendoor Technologies Inc. (OPEN). On earnings-per-share growth, the picture is similar: InfuSystem Holdings, Inc. grew EPS 181. 8% year-over-year, compared to -203. 6% for Opendoor Technologies Inc.. Over a 3-year CAGR, FORA leads at 22. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — FORA or CSGP or Z or INFU or OPEN?
InfuSystem Holdings, Inc.
(INFU) is the more profitable company, earning 4. 6% net margin versus -29. 7% for Opendoor Technologies Inc. — meaning it keeps 4. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: INFU leads at 8. 3% versus -8. 2% for FORA. At the gross margin level — before operating expenses — CSGP leads at 75. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is FORA or CSGP or Z or INFU or OPEN more undervalued right now?
On forward earnings alone, Zillow Group, Inc.
Class C (Z) trades at 14. 1x forward P/E versus 22. 2x for InfuSystem Holdings, Inc. — 8. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for Z: 111. 0% to $67. 75.
08Which pays a better dividend — FORA or CSGP or Z or INFU or OPEN?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is FORA or CSGP or Z or INFU or OPEN better for a retirement portfolio?
For long-horizon retirement investors, Forian Inc.
(FORA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 21)). Opendoor Technologies Inc. (OPEN) carries a higher beta of 3. 14 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (FORA: -90. 5%, OPEN: -58. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between FORA and CSGP and Z and INFU and OPEN?
These companies operate in different sectors (FORA (Healthcare) and CSGP (Real Estate) and Z (Communication Services) and INFU (Healthcare) and OPEN (Real Estate)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: FORA is a small-cap high-growth stock; CSGP is a mid-cap high-growth stock; Z is a small-cap high-growth stock; INFU is a small-cap quality compounder stock; OPEN is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.